Author
Listed:
- Deepika Neelakantan
(University of Colorado–Denver
Molecular Biology Program, University of Colorado Anschutz Medical Campus)
- Hengbo Zhou
(University of Colorado–Denver
Cancer Biology Program, University of Colorado Anschutz Medical Campus)
- Michael U. J. Oliphant
(University of Colorado–Denver
Integrated Physiology Program, University of Colorado Anschutz Medical Campus)
- Xiaomei Zhang
(Lester and Sue Smith Breast Center, Baylor College of Medicine)
- Lukas M. Simon
(Institute of Computational Biology, Helmholtz Zentrum München (GmbH))
- David M. Henke
(Baylor College of Medicine)
- Chad A. Shaw
(Baylor College of Medicine)
- Meng-Fen Wu
(Lester and Sue Smith Breast Center, Baylor College of Medicine)
- Susan G. Hilsenbeck
(Lester and Sue Smith Breast Center, Baylor College of Medicine
Baylor College of Medicine)
- Lisa D. White
(Baylor College of Medicine
Baylor College of Medicine)
- Michael T. Lewis
(Lester and Sue Smith Breast Center, Baylor College of Medicine
Baylor College of Medicine)
- Heide L. Ford
(University of Colorado–Denver
Molecular Biology Program, University of Colorado Anschutz Medical Campus
Cancer Biology Program, University of Colorado Anschutz Medical Campus
Integrated Physiology Program, University of Colorado Anschutz Medical Campus)
Abstract
Recent fate-mapping studies concluded that EMT is not required for metastasis of carcinomas. Here we challenge this conclusion by showing that these studies failed to account for possible crosstalk between EMT and non-EMT cells that promotes dissemination of non-EMT cells. In breast cancer models, EMT cells induce increased metastasis of weakly metastatic, non-EMT tumour cells in a paracrine manner, in part by non-cell autonomous activation of the GLI transcription factor. Treatment with GANT61, a GLI1/2 inhibitor, but not with IPI 926, a Smoothened inhibitor, blocks this effect and inhibits growth in PDX models. In human breast tumours, the EMT-transcription factors strongly correlate with activated Hedgehog/GLI signalling but not with the Hh ligands. Our findings indicate that EMT contributes to metastasis via non-cell autonomous effects that activate the Hh pathway. Although all Hh inhibitors may act against tumours with canonical Hh/GLI signalling, only GLI inhibitors would act against non-canonical EMT-induced GLI activation.
Suggested Citation
Deepika Neelakantan & Hengbo Zhou & Michael U. J. Oliphant & Xiaomei Zhang & Lukas M. Simon & David M. Henke & Chad A. Shaw & Meng-Fen Wu & Susan G. Hilsenbeck & Lisa D. White & Michael T. Lewis & Hei, 2017.
"EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells,"
Nature Communications, Nature, vol. 8(1), pages 1-14, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15773
DOI: 10.1038/ncomms15773
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15773. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.